NAD+: The Molecule Every Cell Needs, and Loses With Age

The short version

NAD+ is not a lab-made peptide like the other compounds on this guide — it is a molecule every single cell in the body already makes and cannot survive without. Its main job is acting like a rechargeable battery for metabolism: cells use it to shuttle the energy released from food into a usable form, and they also use it up as fuel for repair and maintenance jobs like fixing damaged DNA.

The reason NAD+ shows up constantly in research-peptide and longevity conversations is simple: tissue levels of it measurably decline with age. That has led to a wave of interest in "NAD+ boosting" — through direct NAD+ supplements, precursor molecules like NMN and NR, or IV infusions. The honest state of the science, covered below, is that raising blood NAD+ is well established; proving that raising it changes a real health outcome in people is still a work in progress.

What it is

NAD+, short for nicotinamide adenine dinucleotide, is built from two smaller pieces — a nicotinamide unit and an adenine unit — joined by a bridge of two phosphate groups. It exists in two interconvertible forms: an oxidized form (NAD+) and a reduced form (NADH), and cells constantly flip between the two as part of normal metabolism. Two other names show up often in this space: NMN (nicotinamide mononucleotide) and NR (nicotinamide riboside), both of which are smaller "precursor" molecules the body converts into NAD+ after absorption — the rationale being that oral NAD+ itself is poorly taken up by cells intact, so most researchers focus on these precursors instead.

How it works

NAD+ has two separate jobs inside a cell. The first is as a redox carrier — a molecule that ferries electrons through the chemical steps (glycolysis, the TCA cycle, and the mitochondria's power-generating machinery) that turn food into ATP, the energy currency cells actually spend. The second job is as a substrate: a group of enzymes, including sirtuins (involved in gene regulation and stress response) and PARPs (involved in repairing damaged DNA), consume NAD+ directly to do their work. A third enzyme, CD38, also consumes NAD+ and appears to become more active with age, which is one leading explanation for why NAD+ levels fall over time — there is simply more of an enzyme around competing to use it up ^[9][11].

What the research shows

Human review of the evidence (2025). A comprehensive review of NAD+ precursor trials in aging concluded that human studies have shown limited efficacy so far, that age-related NAD+ decline itself has only been directly observed in a handful of human studies, and that far more tissue-specific (rather than just blood) data is needed before drawing firm conclusions ^[6]. This is the most current expert synthesis of where the human evidence actually stands.

NMN raises blood NAD+ and improved walking distance. In a multicenter, placebo-controlled trial in middle-aged adults, 60 days of oral NMN (300-900 mg per day) raised blood NAD+ in a dose-dependent way and improved walking distance and quality-of-life scores compared with placebo, with 600 mg per day identified as the best-performing dose and no safety concerns at any dose tested ^[7].

NMN and insulin sensitivity. In prediabetic, postmenopausal women, 10 weeks of oral NMN (250 mg per day) measurably improved how sensitive muscle tissue was to insulin, though it did not change body composition or long-term blood-sugar averages ^[8].

NR raises blood NAD+ in a dose-dependent way. In healthy overweight adults, 8 weeks of nicotinamide riboside at 100, 300, and 1,000 mg per day raised whole-blood NAD+ by 22%, 51%, and 142% respectively, without causing flushing or any meaningful difference in side effects from placebo ^[10].

Mouse data on the aging mechanism. Removing the CD38 enzyme in mice protects them from the usual age-related drop in NAD+ and preserves mitochondrial function — supporting CD38 as a key driver of the decline ^[11].

Heart-failure research. In a 2025 study combining human heart tissue and a mouse model of a common form of heart failure, restoring NAD+ activated a fat-burning enzyme in heart muscle and improved heart function — an effect that disappeared when that enzyme was removed, tying the benefit specifically to that pathway ^[12].

Reported effects, cautions & safety

There is no verified community-report dataset for NAD+ in this guide's source material, so instead of anecdotal patterns, this section leans directly on the published cautions and open questions in the research literature.

• Efficacy is still unsettled. A 2025 review found human trials of NAD+ precursors have shown limited efficacy so far, and cautioned against over-relying on rodent studies that do not always translate to people ^[6].
• Oral NAD+ itself may not do much. Many researchers consider plain oral NAD+ capsules poorly absorbed intact by cells, which is why most current research focuses on precursor molecules like NMN and NR instead.
• IV and injectable NAD+ carry their own risks. "NAD+ IV therapy" is marketed widely by wellness clinics on comparatively thin controlled evidence, and infusions run too quickly have been linked to chest or abdominal discomfort, flushing, and nausea. Compounded injectable NAD+ has also been the subject of a regulatory recall over bacterial contamination concerns.
• A theoretical cancer question. Because NAD+ supports the metabolism of any rapidly dividing cell, including cancer cells, some researchers flag a theoretical concern about boosting it in people with an active or recent malignancy — this is a mechanism-based caution, not a demonstrated harm.
• Regulatory status is unsettled for NMN specifically. In the United States, NMN's status as a dietary supplement has been challenged on the grounds that it was first investigated as a drug, creating real marketplace uncertainty about what is and is not legally sold as a supplement.
• Product quality varies. Supplement-grade NAD+, NMN, and NR products differ widely in purity and actual content, and third-party testing is not guaranteed across brands.

Where it fits in Research Peptide Fundamentals

NAD+ is the compound most readers land on first, and it sits in the middle of this guide's regulatory spectrum: further along than a pure research chemical like Ipamorelin, but nowhere near as thoroughly proven in human trials as the approved drugs Semaglutide and Tesamorelin. Its appeal is universal — every cell needs it — which is exactly why the evidence question (does raising it change a real outcome, not just a blood number) matters so much. See how all four compare on the comparison page.